Cerebrovascular disease, beta-amyloid, and cognition in aging

Natalie L. Marchant, Bruce R Reed, Charles DeCarli, Cindee M. Madison, Michael W. Weiner, Helena C. Chui, William J. Jagust

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

The present study evaluated cerebrovascular disease (CVD), β-amyloid (Aβ), and cognition in clinically normal elderly adults. Fifty-four participants underwent magnetic resonance imaging (MRI), Pittsburgh compound B (PIB)-positron emission tomography (PET) imaging, and neuropsychological evaluation. High white matter hyperintensity burden and/or presence of infarct defined CVD status (CVD-: n = 27; CVD+: n = 27). PIB-positron emission tomography ratios of Aβ deposition were extracted using Logan plotting (cerebellar reference). Presence of high levels of Aβ in prespecified regions determined PIB status (PIB-: n = 33; PIB+: n = 21). Executive functioning and episodic memory were measured using composite scales. CVD and Aβ, defined as dichotomous or continuous variables, were unrelated to one another. CVD+ participants showed lower executive functioning (p = 0.001) when compared with CVD- individuals. Neither PIB status nor amount of Aβ affected cognition (ps ≥ 0.45), and there was no statistical interaction between CVD and PIB on either cognitive measure. Within this spectrum of normal aging CVD and Aβ aggregation appear to be independent processes with CVD primarily affecting cognition.

Original languageEnglish (US)
Pages (from-to)1006.e25-1006.e36
JournalNeurobiology of Aging
Volume33
Issue number5
DOIs
StatePublished - Jan 1 2012

Fingerprint

Cerebrovascular Disorders
Amyloid
Cognition
Positron-Emission Tomography
Episodic Memory
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
Magnetic Resonance Imaging

Keywords

  • Cerebrovascular disease
  • Cognition
  • Episodic memory
  • Executive functioning
  • PIB

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Marchant, N. L., Reed, B. R., DeCarli, C., Madison, C. M., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2012). Cerebrovascular disease, beta-amyloid, and cognition in aging. Neurobiology of Aging, 33(5), 1006.e25-1006.e36. https://doi.org/10.1016/j.neurobiolaging.2011.10.001

Cerebrovascular disease, beta-amyloid, and cognition in aging. / Marchant, Natalie L.; Reed, Bruce R; DeCarli, Charles; Madison, Cindee M.; Weiner, Michael W.; Chui, Helena C.; Jagust, William J.

In: Neurobiology of Aging, Vol. 33, No. 5, 01.01.2012, p. 1006.e25-1006.e36.

Research output: Contribution to journalArticle

Marchant, NL, Reed, BR, DeCarli, C, Madison, CM, Weiner, MW, Chui, HC & Jagust, WJ 2012, 'Cerebrovascular disease, beta-amyloid, and cognition in aging', Neurobiology of Aging, vol. 33, no. 5, pp. 1006.e25-1006.e36. https://doi.org/10.1016/j.neurobiolaging.2011.10.001
Marchant, Natalie L. ; Reed, Bruce R ; DeCarli, Charles ; Madison, Cindee M. ; Weiner, Michael W. ; Chui, Helena C. ; Jagust, William J. / Cerebrovascular disease, beta-amyloid, and cognition in aging. In: Neurobiology of Aging. 2012 ; Vol. 33, No. 5. pp. 1006.e25-1006.e36.
@article{7ed93f85127a444888d010b451c50e3d,
title = "Cerebrovascular disease, beta-amyloid, and cognition in aging",
abstract = "The present study evaluated cerebrovascular disease (CVD), β-amyloid (Aβ), and cognition in clinically normal elderly adults. Fifty-four participants underwent magnetic resonance imaging (MRI), Pittsburgh compound B (PIB)-positron emission tomography (PET) imaging, and neuropsychological evaluation. High white matter hyperintensity burden and/or presence of infarct defined CVD status (CVD-: n = 27; CVD+: n = 27). PIB-positron emission tomography ratios of Aβ deposition were extracted using Logan plotting (cerebellar reference). Presence of high levels of Aβ in prespecified regions determined PIB status (PIB-: n = 33; PIB+: n = 21). Executive functioning and episodic memory were measured using composite scales. CVD and Aβ, defined as dichotomous or continuous variables, were unrelated to one another. CVD+ participants showed lower executive functioning (p = 0.001) when compared with CVD- individuals. Neither PIB status nor amount of Aβ affected cognition (ps ≥ 0.45), and there was no statistical interaction between CVD and PIB on either cognitive measure. Within this spectrum of normal aging CVD and Aβ aggregation appear to be independent processes with CVD primarily affecting cognition.",
keywords = "Cerebrovascular disease, Cognition, Episodic memory, Executive functioning, PIB",
author = "Marchant, {Natalie L.} and Reed, {Bruce R} and Charles DeCarli and Madison, {Cindee M.} and Weiner, {Michael W.} and Chui, {Helena C.} and Jagust, {William J.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.neurobiolaging.2011.10.001",
language = "English (US)",
volume = "33",
pages = "1006.e25--1006.e36",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Cerebrovascular disease, beta-amyloid, and cognition in aging

AU - Marchant, Natalie L.

AU - Reed, Bruce R

AU - DeCarli, Charles

AU - Madison, Cindee M.

AU - Weiner, Michael W.

AU - Chui, Helena C.

AU - Jagust, William J.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The present study evaluated cerebrovascular disease (CVD), β-amyloid (Aβ), and cognition in clinically normal elderly adults. Fifty-four participants underwent magnetic resonance imaging (MRI), Pittsburgh compound B (PIB)-positron emission tomography (PET) imaging, and neuropsychological evaluation. High white matter hyperintensity burden and/or presence of infarct defined CVD status (CVD-: n = 27; CVD+: n = 27). PIB-positron emission tomography ratios of Aβ deposition were extracted using Logan plotting (cerebellar reference). Presence of high levels of Aβ in prespecified regions determined PIB status (PIB-: n = 33; PIB+: n = 21). Executive functioning and episodic memory were measured using composite scales. CVD and Aβ, defined as dichotomous or continuous variables, were unrelated to one another. CVD+ participants showed lower executive functioning (p = 0.001) when compared with CVD- individuals. Neither PIB status nor amount of Aβ affected cognition (ps ≥ 0.45), and there was no statistical interaction between CVD and PIB on either cognitive measure. Within this spectrum of normal aging CVD and Aβ aggregation appear to be independent processes with CVD primarily affecting cognition.

AB - The present study evaluated cerebrovascular disease (CVD), β-amyloid (Aβ), and cognition in clinically normal elderly adults. Fifty-four participants underwent magnetic resonance imaging (MRI), Pittsburgh compound B (PIB)-positron emission tomography (PET) imaging, and neuropsychological evaluation. High white matter hyperintensity burden and/or presence of infarct defined CVD status (CVD-: n = 27; CVD+: n = 27). PIB-positron emission tomography ratios of Aβ deposition were extracted using Logan plotting (cerebellar reference). Presence of high levels of Aβ in prespecified regions determined PIB status (PIB-: n = 33; PIB+: n = 21). Executive functioning and episodic memory were measured using composite scales. CVD and Aβ, defined as dichotomous or continuous variables, were unrelated to one another. CVD+ participants showed lower executive functioning (p = 0.001) when compared with CVD- individuals. Neither PIB status nor amount of Aβ affected cognition (ps ≥ 0.45), and there was no statistical interaction between CVD and PIB on either cognitive measure. Within this spectrum of normal aging CVD and Aβ aggregation appear to be independent processes with CVD primarily affecting cognition.

KW - Cerebrovascular disease

KW - Cognition

KW - Episodic memory

KW - Executive functioning

KW - PIB

UR - http://www.scopus.com/inward/record.url?scp=85058205414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058205414&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2011.10.001

DO - 10.1016/j.neurobiolaging.2011.10.001

M3 - Article

C2 - 22048124

AN - SCOPUS:84858341309

VL - 33

SP - 1006.e25-1006.e36

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 5

ER -